Meynert基底核脑深部电刺激治疗帕金森病痴呆的随机临床试验
该随机双盲交叉试验纳入6例伴运动波动的帕金森病痴呆患者,比较双侧低频(20 Hz)Meynert基底核脑深部电刺激与假刺激各6周的差异。手术与刺激耐受良好,主要认知结局未见一致改善,但神经精神量表评分在刺激期优于假刺激期。
要点
- 低频Meynert基底核DBS在帕金森病痴呆患者中安全性可接受,未见严重不良事件。
- 主要认知结局及静息态功能磁共振未见一致改善。
- 神经精神量表评分刺激期较假刺激期改善,提示可能对神经精神症状有益。
核心结论
- 低频Meynert基底核DBS在帕金森病痴呆患者中可安全实施,但主要认知结局未见改善。
- 神经精神量表评分在刺激期优于假刺激期,值得进一步研究其改善神经精神症状的潜力。
研究设计与样本
- 随机双盲交叉临床试验,纳入6例在英国神经外科转诊中心治疗的帕金森病痴呆患者,时间为2012年10月26日至2015年7月31日。
- 患者入选条件包括符合帕金森病痴呆诊断标准、伴运动波动、年龄35至80岁、简易精神状态检查评分21至26分、磁共振示轻微萎缩并与照护者同住。
主要发现
- 6例患者均为男性,平均(SD)年龄65.2(10.7)岁,手术与刺激均耐受良好,试验期间无严重不良事件。
- 主要认知结局各项及静息态功能磁共振结果均未见一致改善。
关键数值与推荐
- 干预为双侧低频(20 Hz)Meynert基底核DBS或假刺激,各持续6周后交叉。
- 主要结局为简版认知 battery 各项目评分在两种条件间的差异。
- 次要结局为认知、精神及运动症状标准化测量与静息态功能磁共振的探索性差异。
临床怎么用
- 对帕金森病痴呆患者,低频Meynert基底核DBS不宜以改善认知为主要目的开展。
- 其改善神经精神症状的潜力尚需进一步研究验证,暂不作为常规治疗推荐。
局限性
- 样本量仅6例,结果解释受限。
- 主要认知结局为各认知测验项目分别比较,未报告整体认知复合终点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Deep brain stimulation of the nucleus basalis of Meynert (NBM DBS) has been proposed as a treatment option for Parkinson disease dementia. OBJECTIVE: To evaluate the safety and potential symptomatic effects of NBM DBS in patients with Parkinson disease dementia. DESIGN, SETTING, AND PARTICIPANTS: A randomized, double-blind, crossover clinical trial evaluated the results of 6 patients with Parkinson disease dementia who were treated with NBM DBS at a neurosurgical referral center in the United Kingdom from October 26, 2012, to July 31, 2015. Eligible patients met the diagnostic criteria for Parkinson disease dementia, had motor fluctuations, were appropriate surgical candidates aside from the coexistence of dementia, were age 35 to 80 years, were able to give informed consent, had a Mini-Mental State Examination score of 21 to 26, had minimal atrophy seen on results of brain magnetic resonance imaging, and lived at home with a caregiver-informant. INTERVENTIONS: After surgery, patients were assigned to receive either active stimulation (bilateral, low-frequency [20 Hz] NBM DBS) or sham stimulation for 6 weeks, followed by the opposite condition for 6 weeks. MAIN OUTCOMES AND MEASURES: The primary outcome was the difference in scores on each item of an abbreviated cognitive battery (California Verbal Learning Test-II, Wechsler Adult Intelligence Scale-III digit span, verbal fluency, Posner covert attention test, and simple and choice reaction times) between the 2 conditions. Secondary outcomes were exploratory and included differences in scores on standardized measurements of cognitive, psychiatric, and motor symptoms and resting state functional magnetic resonance imaging. RESULTS: Surgery and stimulation were well tolerated by all 6 patients (all men; mean [SD] age, 65.2 [10.7] years), with no serious adverse events during the trial. No consistent improvements were observed in the primary cognitive outcomes or in results of resting state functional magnetic resonance imaging. An improvement in scores on the Neuropsychiatric Inventory was observed with NBM DBS (8.5 points [range, 4-26 points]) compared with sham stimulation (12 points [range, 8-38 points]; median difference, 5 points; 95% CI, 2.5-8.5 points; P = .03) and the preoperative baseline (13 points [range, 5-25 points]; median difference, 2 points; 95% CI, -8 to 5.5 points; P = .69). CONCLUSIONS AND RELEVANCE: Low-frequency NBM DBS was safely conducted in patients with Parkinson disease dementia; however, no improvements were observed in the primary cognitive outcomes. Further studies may be warranted to explore its potential to improve troublesome neuropsychiatric symptoms. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01701544.
引用
- Gratwicke J, Zrinzo L, Kahan J, et al. Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia: A Randomized Clinical Trial. JAMA Neurol. 2018. PMID: 29255885. doi:10.1001/jamaneurol.2017.3762
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。